Cephalosporin combination drug - China Pharma HoldingsAlternative Names: Anti-drug-resistant cehphalosporin
Latest Information Update: 08 Apr 2015
At a glance
- Originator China Pharma Holdings; Hainan Helpson Bio-Pharmaceutical
- Mechanism of Action Cell wall inhibitors; Enzyme inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Bacterial infections
Most Recent Events
- 31 Mar 2015 Cephalosporin combination drug is still in phase II trials for Bacterial infections in China
- 15 Mar 2012 Cephalosporin combination drug is still in phase II trials for Bacterial infections in China
- 11 Nov 2010 Phase-II clinical trials in Bacterial infections in China (unspecified route)